Immediate Impact

1 from Science/Nature 63 standout
Sub-graph 1 of 23

Citing Papers

Non-Hodgkin lymphoma
2017 Standout
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
2016 Standout
3 intermediate papers

Works of Michel Legros being referenced

The Use of a Sequential High Dose Recombinant Interleukin 2 Regimen After Autologous Bone Marrow Transplantation Does Not Improve the Disease Free Survival of Patients with Acute Leukemia Transplanted in First Complete Remission
1997
Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.
1992

Author Peers

Author Last Decade Papers Cites
Michel Legros 394 82 143 233 162 55 808
Vladimír Koza 244 127 252 329 174 47 812
Karin Tiedemann 158 28 92 295 78 42 791
Shuangshuang Fu 286 74 37 220 116 40 840
Rado Kenda 306 38 186 43 276 39 890
Willem M. Smit 422 38 71 370 60 35 918
Rajive Kumar 144 26 85 313 142 96 939
Priya Kumar 199 107 188 58 87 59 744
Yee Chung Cheng 448 22 99 147 164 39 729
J.M. Cosset 239 72 256 176 125 42 786
H. Evin Gulbahce 352 19 220 130 46 63 896

All Works

Loading papers...

Rankless by CCL
2026